Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Chemo Combo Wins in Ovarian Cancer, But Single-Agent Therapy Still in the Game

Chemo Combo Wins in Ovarian Cancer, But  Single-Agent Therapy Still in the Game
ShareXFacebook

(MedPage Today) -- SAN JUAN, PUERTO RICO -- A negative study in low-grade serous ovarian cancer might have uncovered a pathway toward more effective treatment for a large subgroup of patients, according to the NRG-GY019 trial. The randomized...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

AI and the New Folie a Deux
MedPage Today

AI and the New Folie a Deux

(MedPage Today) -- Artificial intelligence (AI) is rapidly becoming part of our patients' inner lives. In medical practice, we are accustomed to asking about relationships, stressors, substances, and sleep. Increasingly, however, we must also ask...

Read more →
Advertisement